We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$349B
AUM Growth
-$1.04B
Cap. Flow
+$12.6B
Cap. Flow %
3.6%
Top 10 Hldgs %
18.46%
Holding
3,713
New
104
Increased
2,394
Reduced
623
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 22.03%
2 Healthcare 12.31%
3 Financials 11.79%
4 Consumer Discretionary 9.84%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIVI icon
3426
BioVie
BIVI
$11.5M
$39.6K ﹤0.01%
116
SDC
3427
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$39.4K ﹤0.01%
95,034
JOB icon
3428
GEE Group
JOB
$23.1M
$39.4K ﹤0.01%
66,522
TRML
3429
DELISTED
Tourmaline Bio
TRML
$38.5K ﹤0.01%
1,371
AXTI icon
3430
AXT Inc
AXTI
$3.95B
$38.1K ﹤0.01%
15,887
LVO icon
3431
LiveOne
LVO
$61.7M
$38K ﹤0.01%
3,979
RLMD icon
3432
Relmada Therapeutics
RLMD
$557M
$37.5K ﹤0.01%
12,505
MNOV icon
3433
MediciNova
MNOV
$65.5M
$37.3K ﹤0.01%
17,843
IMUX icon
3434
Immunic
IMUX
$190M
$36.8K ﹤0.01%
2,500
LNSR icon
3435
LENSAR
LNSR
$61.5M
$36.6K ﹤0.01%
11,846
GAN
3436
DELISTED
GAN Ltd
GAN
$36.5K ﹤0.01%
31,476
SNCR
3437
DELISTED
Synchronoss Technologies
SNCR
$36.3K ﹤0.01%
4,207
PRAX icon
3438
Praxis Precision Medicines
PRAX
$8.58B
$36.2K ﹤0.01%
1,410
NAGE
3439
Niagen Bioscience
NAGE
$271M
$36K ﹤0.01%
24,667
STXS icon
3440
Stereotaxis
STXS
$126M
$35.9K ﹤0.01%
22,696
QMCO icon
3441
Quantum Corp
QMCO
$419M
$35.3K ﹤0.01%
2,890
MCHX icon
3442
Marchex
MCHX
$76.2M
$35.3K ﹤0.01%
24,313
LPTH icon
3443
Lightpath Technologies
LPTH
$651M
$35.1K ﹤0.01%
24,173
SPRO icon
3444
Spero Therapeutics
SPRO
$67.7M
$34.6K ﹤0.01%
28,565
SPRB
3445
Spruce Biosciences
SPRB
$118M
$34.6K ﹤0.01%
204
DMAC icon
3446
DiaMedica Therapeutics
DMAC
$342M
$34.2K ﹤0.01%
13,251
BDSX icon
3447
Biodesix
BDSX
$220M
$34K ﹤0.01%
1,031
ATOS icon
3448
Atossa Therapeutics
ATOS
$20.6M
$33.9K ﹤0.01%
3,064
DRIO icon
3449
DarioHealth
DRIO
$70.9M
$33.8K ﹤0.01%
515
CBIO
3450
Crescent Biopharma
CBIO
$537M
$33.5K ﹤0.01%
224

Similar funds

Charles Schwab's Q3 2023 Portfolio in Review

As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.

  • Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
  • Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
  • Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
  • Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
  • Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
  • Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
  • Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.